Orthofix Medical (OFIX) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn | -20.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.54% |
| Dec 31, 2025 | 13.59% |
| Sep 30, 2025 | 14.94% |
| Jun 30, 2025 | 20.60% |
| Mar 31, 2025 | 14.30% |
| Dec 31, 2024 | 21.83% |
| Sep 30, 2024 | 19.35% |
| Jun 30, 2024 | 36.60% |
| Mar 31, 2024 | 33.23% |
| Dec 31, 2023 | -5.96% |
| Sep 30, 2023 | 17.77% |
| Jun 30, 2023 | 41.26% |
| Mar 31, 2023 | 49.98% |
| Dec 31, 2022 | 5.75% |
| Sep 30, 2022 | -6.81% |
| Jun 30, 2022 | -8.64% |
| Mar 31, 2022 | -8.66% |
| Dec 31, 2021 | 31.53% |
| Sep 30, 2021 | -9.95% |
| Jun 30, 2021 | -9.18% |
| Mar 31, 2021 | -1.69% |
| Dec 31, 2020 | 3.52% |
| Sep 30, 2020 | 1.88% |
| Jun 30, 2020 | 20.64% |
| Mar 31, 2020 | 11.07% |
| Dec 31, 2019 | 2.97% |
| Sep 30, 2019 | -10.46% |
| Jun 30, 2019 | 45.14% |
| Mar 31, 2019 | 39.39% |
| Dec 31, 2017 | 28.42% |
| Sep 30, 2017 | 28.05% |
| Jun 30, 2017 | 31.16% |
| Mar 31, 2017 | 33.37% |
| Dec 31, 2016 | 34.89% |
| Sep 30, 2016 | 85.43% |
| Jun 30, 2016 | 8.59% |
| Mar 31, 2016 | 2.61% |
| Dec 31, 2014 | 0.82% |
| Sep 30, 2014 | 10.08% |
| Jun 30, 2014 | -20.63% |
| Mar 31, 2014 | -7.69% |
| Dec 31, 2013 | 15.27% |
| Sep 30, 2013 | -8.66% |